Delivery Order SPE2DB22D1106-SPE2DB24FETF6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,097.08 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 mL vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,041.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Docetaxel 160 mg/16 ml vials on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-competitive set-aside delivery order represents a pharmaceutical supply transaction fulfilling military healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,975,167 units of Docetaxel 80 mg/4 ml vial 4 ml, a specialty medication. The contract has a firm fixed price of $1,317.74 and a completion date of January 21, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,574.73 for Docetaxel 160 mg/16 mL vials on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Docetaxel is a chemotherapy medication used primarily in cancer treatment protocols across military and federal...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The order, valued at $10,608.90, is for the provision of pharmaceutical products and medical supplies. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,572.16 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,670.70 by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of pharmaceutical products and medical supplies. The delivery order, valued at $18,404.40, is a firm-fixed-price contract with a period of performance through September 6, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide a range of products including specialty...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $26,038.00 contract is for the supply of pharmaceutical products and medical supplies, with an ultimate completion date of April 23, 2024. Amerisourcebergen is a major supplier to the U.S. Department of Defense and Veterans Affairs healthcare systems, leveraging its extensive pharmaceutical distribution network. The...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $14,878.08, is for the supply of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. AmerisourceBergen, a major pharmaceutical distribution company, leverages its extensive supply chain network to fulfill this...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FETF6Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order, valued at $1,387.22, is for the supply of 4,564,688,768 mL of the pharmaceutical product Docetaxel 160 mg/16 mL. The order has a firm fixed-price pricing type and a completion date of May 23, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for AmerisourceBergen to deliver a wide range of essential medical products to the DoD worldwide. This specific delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/22/24 |